Listen to an audio podcast of the November 28, 2023, FDA Drug Safety Communication, FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan).
Similar Posts
Empower Clinic Services LLC dba Empower Pharmacy. Houston, TX. 483 issued 11/14/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/14/2025
Short Title (70 char) Empower Clinic Services LLC dba Empower Pharmacy. Houston, TX. 483 issued 11/14/2025
FEI Number 3021758709
Firm Name Empower Clinic Services LLC dba Empower Pharmacy
Record TypeInfusion Pump Correction: ICU Medical, Inc. Issues Correction for Plum Duo Infusion System Due to Software Possibly Resulting in Pump Becoming Unresponsive
ICU Medical is correcting the Plum Duo infusion system due to pump software issues that may cause the device to become unresponsive.Natco Pharma Limited – 672564 – 09/25/2025
CGMP/Finished Pharmaceuticals/AdulteratedList of Drug Master Files (DMFs)
The list is updated quarterly. Changes are made to the DMF activity status, DMF type, holder name, and subject.Decision: Advertising Investigations: June 2025
Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.
Nirogacestat hydrobromide approved to treat desmoid tumours
As with any medicine, the MHRA will keep the safety and effectiveness of Nirogacestat hydrobromide under close review.